CAS 2241664-16-2

JNJ 4796)

Description:

JNJ 4796, identified by its CAS number 2241664-16-2, is a chemical compound that belongs to a class of substances known for their potential therapeutic applications, particularly in the field of neuroscience. This compound is characterized by its specific molecular structure, which includes various functional groups that contribute to its biological activity. JNJ 4796 has been studied for its effects on neurotransmitter systems, and it may exhibit properties that modulate synaptic transmission or neuronal signaling pathways. The compound's pharmacokinetics, including absorption, distribution, metabolism, and excretion, are crucial for understanding its efficacy and safety profile in clinical settings. Additionally, ongoing research may explore its potential in treating conditions such as neurodegenerative diseases or psychiatric disorders. As with any investigational drug, comprehensive studies are necessary to fully elucidate its mechanism of action, therapeutic potential, and any associated side effects.

Formula: C₂₈H₂₇N₉O₃

Synonyms:

• Acetamide, N-[2-[2-[[4-[(R)-(2-methyl-2H-tetrazol-5-yl)phenylmethyl]-1-piperazinyl]carbonyl]-4-pyridinyl]-5-benzoxazolyl]-
• (R)-N-(2-(2-(4-((2-methyl-2H-tetrazol-5-yl)(phenyl)methyl)piperazine-1-carbonyl)pyridin-4-yl)benzo[d]oxazol-5-yl)acetamide
• JNJ 4796)
• (JNJ-4796
• JNJ4796

JNJ 4796

CAS: 2241664-16-2

JNJ-4796 is an antiviral compound with a mode of action that inhibits hemagglutinin-mediated fusion in influenza A viruses. It is used for preventing and treating influenza infections.

Formula: C₂₈H₂₇N₉O₃

Purity: Min. 95%

Molecular weight: 537.6 g/mol

Ref: 3D-RPD66416

JNJ4796

CAS: 2241664-16-2

JNJ4796 is an oral fusion inhibitor that neutralizes influenza A group 1 by blocking HA-mediated fusion, mimicking bnAbs.

Formula: C₂₈H₂₇N₉O₃

Purity: 98%

Color and Shape: Solid

Molecular weight: 537.57

Ref: TM-T15625